NASDAQ:XENE | Cash Flow Statement | Xenon Pharmaceuticals Inc.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$110.74M
2026-03-31-$102.3M-$88.9M$133,000.00-$407.28M$843.01M
2025-12-31-$105.26M-$81.48M$318,000.00$62.7M$113.54M
2025-09-30-$90.9M
2025-06-30-$84.71M
2025-03-31-$65.05M-$61.65M$43,000.00$34.51M$1.15M
2024-12-31-$65.69M-$54.39M$783,000.00$98.5M$12.13M
2024-09-30-$62.79M
2024-06-30-$57.92M
2024-03-31-$47.93M-$46.19M$188,000.00-$43.19M$0.00
2023-12-31-$44.74M-$35.4M$78,000.00-$239.79M$324.01M
2023-09-30-$48.46M
2023-06-30-$47.46M
2023-03-31-$41.73M-$34.41M$2.21M$46.62M
2022-12-31-$37.4M-$35.33M$1.75M-$11.74M$6,000.00
2022-09-30-$37.15M
2022-06-30-$31.16M
2022-03-31-$19.67M-$18.43M$212,000.00-$48.89M$7.88M
2021-12-31-$25.56M-$20.71M$514,000.00-$215.43M$323.95M
2021-09-30-$15.45M
2021-06-30-$22.11M
2021-03-31-$15.76M-$20.71M$404,000.00-$55.1M$118.72M
2020-12-31-$12.32M-$13.11M$828,000.00$43.2M$45,000.00
2020-09-30-$8.86M
2020-06-30-$175,000.00
2020-03-31-$7.48M-$13.07M$647,000.00-$52.93M$102.47M
2019-12-31-$11.38M$19.79M$595,000.00-$60.32M$27.43M
2019-09-30-$8.87M
2019-06-30-$10.01M
2019-03-31-$11.34M-$8.67M$335,000.00-$7.03M$58,000.00
2018-12-31-$8.56M-$7.24M$170,000.00-$12.56M$34,000.00
2018-09-30-$14.38M
2018-06-30-$7.8M
2018-03-31-$3.76M-$8.22M$181,000.00$4.98M$119,000.00
2017-12-31-$8.07M-$6.84M$63,000.00$5.8M$6.89M
2017-09-30-$7.74M
2017-06-30-$7.38M
2017-03-31-$7.52M-$6.46M$137,000.00
2016-12-31-$6M-$4.67M$28,000.00
2016-09-30-$7.71M
2016-06-30-$6.02M
2016-03-31-$3.26M-$4.94M$83,000.00
2015-12-31-$3.94M-$5.25M$143,000.00
2015-09-30-$3.83M
2015-06-30$1.17M
2015-03-31-$9.16M-$5.55M$84,000.00
2014-12-31$1.22M$205,000.00-$2.95M$776,000.00
2014-09-30$9.19M
2014-06-30$1.23M
2014-03-31$1.37M-$842,000.00$480,000.00
2013-12-31$2.51M$174,000.00-$2.69M$41,000.00
2013-09-30$6.38M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$345.91M-$279.12M$799,000.00$218M$117.11M
2024-12-31-$234.33M-$181.39M$3.08M$165M$12.13M
2023-12-31-$182.39M-$151.11M$5.62M-$111.39M$353.52M
2022-12-31-$125.37M-$101.03M$2.89M-$293.41M$278.47M
2021-12-31-$78.88M-$69.5M$2.05M-$246.77M$447.54M
2020-12-31-$28.84M-$48.12M$2.64M-$16.82M$85.8M
2019-12-31-$41.6M-$4.71M$1.24M-$66.21M$27.52M
2018-12-31-$34.5M-$34.72M$507,000.00-$28.99M$111.59M
2017-12-31-$30.7M-$28.73M$315,000.00$24.29M$7.07M
2016-12-31-$23M-$19.57M$279,000.00
2015-12-31-$15.75M-$18.1M$551,000.00
2014-12-31$13.02M$738,000.00$266,000.00$1.53M
2013-12-31$12.03M$705,000.00-$3.32M$156,000.00
2012-12-31-$4.3M$786,000.00$45.57M$526,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.